Trademark: 88332411
Word
ALERACARE
Status
Dead
Status Code
606
Status Date
Monday, February 26, 2024
Serial Number
88332411
Mark Type
4000
Filing Date
Friday, March 8, 2019
Published for Opposition
Tuesday, May 25, 2021
Abandoned Date
Monday, February 26, 2024

Trademark Owner History
AleraCare Holdings, LLC - Owner At Publication

Classifications
41 Medical educational services, namely, providing courses of instruction in the medical fields of parenteral and enteral therapy and intraperitoneal therapy and treatment; medical education services namely, training for medical professionals and patients regarding the use and application of enteral and parenteral therapy for medical purposes and distributing course materials in connection therewith; medical educational services, namely, providing individualized and group instruction, seminars and workshops for patients and caregivers of patients requiring parenteral and enteral therapy for medical purposes
35 Medical referrals; managed care services, namely, electronic processing of health care and pharmaceutical information; procurement, namely, purchasing pharmaceuticals for others; supplying prescription drugs to health plan participants for the funding organizations
44 Medical services, namely, providing therapy management services relating to the provision of ambulatory infusion therapies and home infusion therapies; Medical provider services, namely, infusion services and injection of pharmaceuticals provided at home and in clinics; nursing services at home and in clinics; Specialty and compounding pharmacy services, namely, dispensing pharmaceuticals, and providing managed health care services in the nature of pharmaceutical and therapy management services to patients, managed care organizations and providers; sterile and non-sterile compounding of pharmaceuticals; Providing medical services in the fields of oncology, hepatitis, Crohn's, immune deficiency, pulmonary, multiple sclerosis, rheumatoid arthritis, interferon, fertility, growth hormone, anti-infectives, hemophilia, osteoarthritis, steroid, hormone replacement, veterinary, respiratory, wound care, transplant, alcohol and opiate dependency, dermatological and nutrition therapy services
42 Providing medical and scientific compounding laboratory services to pharmaceutical manufacturers for new drug applications

Trademark Events
Feb 26, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 26, 2024
Abandonment - No Use Statement Filed
Jul 22, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 20, 2023
Sou Extension 4 Granted
Jul 20, 2023
Sou Extension 4 Filed
Jul 20, 2023
Sou Teas Extension Received
Jul 20, 2023
Teas Change Of Correspondence Received
Jul 20, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 20, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 24, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 20, 2023
Sou Extension 3 Granted
Jan 20, 2023
Sou Extension 3 Filed
Jan 20, 2023
Sou Teas Extension Received
Jul 22, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 20, 2022
Sou Extension 2 Granted
Jul 20, 2022
Sou Extension 2 Filed
Jul 20, 2022
Sou Teas Extension Received
Mar 2, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 1, 2022
Sou Extension 1 Granted
Jan 20, 2022
Sou Extension 1 Filed
Mar 1, 2022
Case Assigned To Intent To Use Paralegal
Jan 24, 2022
Notice Of Revival - E-Mailed
Jan 23, 2022
Sou Extension Received With Teas Petition
Jan 23, 2022
Petition To Revive-Granted
Jan 23, 2022
Teas Petition To Revive Received
Jul 20, 2021
Noa E-Mailed - Sou Required From Applicant
May 25, 2021
Official Gazette Publication Confirmation E-Mailed
May 25, 2021
Published For Opposition
May 5, 2021
Notification Of Notice Of Publication E-Mailed
Apr 21, 2021
Approved For Pub - Principal Register
Apr 21, 2021
Examiner's Amendment Entered
Apr 21, 2021
Notification Of Examiners Amendment E-Mailed
Apr 21, 2021
Examiners Amendment E-Mailed
Apr 21, 2021
Examiners Amendment -Written
Oct 8, 2020
Notification Of Final Refusal Emailed
Oct 8, 2020
Final Refusal E-Mailed
Oct 8, 2020
Final Refusal Written
Aug 22, 2020
Teas/Email Correspondence Entered
Aug 21, 2020
Correspondence Received In Law Office
Aug 21, 2020
Teas Response To Office Action Received
Feb 21, 2020
Notification Of Non-Final Action E-Mailed
Feb 21, 2020
Non-Final Action E-Mailed
Feb 21, 2020
Non-Final Action Written
Jan 21, 2020
Assigned To Examiner
Nov 22, 2019
Teas/Email Correspondence Entered
Nov 21, 2019
Correspondence Received In Law Office
Nov 21, 2019
Teas Response To Office Action Received
May 21, 2019
Notification Of Non-Final Action E-Mailed
May 21, 2019
Non-Final Action E-Mailed
May 21, 2019
Non-Final Action Written
May 17, 2019
Assigned To Examiner
Mar 27, 2019
New Application Office Supplied Data Entered
Mar 12, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24